Feed MCRB
MC
Seres Therapeutics, Inc.
MCRB · NASDAQ
$5.00 +0.20% (+$0.01)
1M -13.35%
Market Cap $48.4M
P/E Ratio 8.50x
Div. Yield -
ROE 14.83%
Bulios Fair Price
$3.58
28.4% downside
Preț actual
$5
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile MCRB sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
46 /100
Fair P/B 1.10x
P/E 8.50x
P/FCF 55.98x
Growth
100 /100
Growing Book val. growth 60.06%
FCF growth N/A
EPS growth N/A
Profitability
50 /100
Moderate Op. margin 11,910.10%
Gross margin 423.83%
FCF margin 109.63%
Quality
27 /100
Poor ROA 4.12%
ROIC 72.70%
Asset turnover 0.01x
Debt
49 /100
Moderate Current ratio 2.56x
Debt/Equity 1.88x
Debt/Assets N/A
Stability
19 /100
Unstable Profitable years 1
Beta 0.21x
EPS volatility 55.27%
Întreabă StockBot despre MCRB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard N. Kender
Employees
66
Headquarters
Cambridge
Evenimente viitoare
04 NOV.
Earnings
Upcoming earnings report